Integrin α2β1 mediates the anti-angiogenic and anti-tumor activities of angiocidin, a novel tumor-associated protein

Overview of attention for article published in Experimental Cell Research, April 2006

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 15 patents

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 15 patents that reference this research output.

Anti-angiogenic treatment using VLO4 with a blocking peptide

Grant US-12053504-B2

United States of America

06 Aug 2024

Combination therapies for inhibiting sprout angiogenesis in the treatment of cancers

Grant US-12053507-B2

United States of America

06 Aug 2024

Anti-angiogenic treatment with a combination of antagonists

Grant US-11318184-B2

United States of America

03 May 2022

N-acyldipeptide derivatives and their uses

Grant US-11224565-B2

United States of America

18 Jan 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 11 additional patents.